Evidence method
Level · gp.fundamentals.debt_to_revenue
17070.72% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BTAI · Dec 31, 2025
BioXcel Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001104659-26-036214General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-8974.30% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-71.67% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
112.46% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
74.45% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-7859.97% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4711.99% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
431.00% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/6 normalizedLevel 3Jun 30, 20230/6 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20246/7 normalizedLevel 3Dec 31, 20246/7 normalizedLevel 3Mar 31, 20256/8 normalizedLevel 3Jun 30, 20256/8 normalizedLevel 3Sep 30, 20257/9 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20267/9 normalizedLevel 3Jun 30, 20267/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 111352.04%
- Current
- 17070.72%
- Delta
- -94281.32%
- Previous
- -19170.41%
- Current
- -8974.30%
- Delta
- 10196.11%
- Previous
- -54.21%
- Current
- -71.67%
- Delta
- -17.46%
- Previous
- 468.37%
- Current
- 112.46%
- Delta
- -355.91%
- Previous
- 88.78%
- Current
- 74.45%
- Delta
- -14.32%
- Previous
- -14518.37%
- Current
- -7859.97%
- Delta
- 6658.40%
- Previous
- 8918.37%
- Current
- 4711.99%
- Delta
- -4206.37%
- Previous
- 592.86%
- Current
- 431.00%
- Delta
- -161.86%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BTAI Fundamental State →Transitioned To · BTAI Fundamental State →Transitioned To · BTAI BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · BTAI CASH_GENERATION_INCREASED →Transitioned To · BTAI GROWTH_DECREASED →Transitioned To · BTAI INVENTORY_PRESSURE_DECREASED →Transitioned To · BTAI MARGIN_DECREASED →Transitioned To · BTAI PROFITABILITY_INCREASED →Transitioned To · BTAI R_AND_D_INTENSITY_DECREASED →Transitioned To · BTAI SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.